Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05340751 · ClinicalTrials.gov registry record
The Effect of Hypotensive Anesthesia on Hemoglobin Levels During Total Knee Arthroplasty
A clinical trial, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- 35
- Enrollment target
NCT05340751: Completed study, sponsored by Hospital for Special Surgery, New York.
NCT05340751 is a clinical trial that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05340751 has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The current study investigates the effect of hypotensive anesthesia on patient hemoglobin levels during primary total knee arthroplasty. Considering that because of the tourniquet there is no blood loss during the first 60 minutes of the procedure changes in hemoglobin during the first 60 minutes should be primarily related to decrease in blood pressure and secondary to fluid loading during hypotensive anesthesia.
Primary Outcome
To investigate the effect of intraoperative fluid substitution during HEA on hemoglobin levels during and after primary TKA.
Interventions
- DIAGNOSTIC_TEST Blood drawn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2014-01-01 |
| Est. Completion | 2014-09-01 |
What the finished NCT05340751 record still lists
NCT05340751 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood drawn is the first listed.
NCT05340751 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05340751 about?
NCT05340751 is a clinical study titled "The Effect of Hypotensive Anesthesia on Hemoglobin Levels During Total Knee Arthroplasty". The current study investigates the effect of hypotensive anesthesia on patient hemoglobin levels during primary total knee arthroplasty. Considering that because of the tourniquet there is no blood loss during the first 60 minutes of the procedure changes in hemoglobin during the first 60 minutes sh...
What is the current status of trial NCT05340751?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2014-01-01. Estimated completion is 2014-09-01.
What interventions are being tested in trial NCT05340751?
The interventions under investigation include: Blood drawn (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05340751?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI